It is interesting to note that GIST-T1 cells are sensitive to the KIT kinase inhibitor imatinib (IC50 = 42 nM) [17], whereas GIST430 cells are resistant to imatinib [18]. This evidence concerns the gene KIT and gastrointestinal stromal tumor.